The process of changing national malaria treatment policy: lessons from country-level studies.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Health Policy and Planning

• Publication date

  2004-11-01

• Fields of study

  Medicine, Environmental Science, Political Science

• Identifiers
  DOI 10.1093/HEAPOL/CZH051PMID 15459161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Choosing the first line drug for malaria treatment - how can cost-effectiveness analysis inform policy?

  2006cited by this paper
• Assuring effective malaria treatment in Africa: drug efficacy is necessary but not sufficient

  2005cited by this paper
• A critical review of behavioral issues related to malaria control in sub-Saharan Africa: what contributions have social scientists made?

  2004cited by this paper
• A framework and toolkit for capturing the communicable disease programmes within health systems: tuberculosis control as an illustrative example.

  2004cited by this paper
• The economic impact of malaria in Africa: a critical review of the evidence.

  2003cited by this paper
• A contrarian view of malaria therapy policy in Africa.

  2003cited by this paper
• Review

  2003cited by this paper
• Trends in antimalarial drug deployment in sub-Saharan Africa

  2003cited by this paper
• Beyond evidence: a retrospective study of factors influencing a malaria treatment policy change in two South African provinces

  2003influential reference
• Generalized cost-effectiveness analysis for national-level priority-setting in the health sector

  2003cited by this paper
• The contribution of health-care services to a sound and sustainable malaria-control policy.

  2003cited by this paper
• The utilisation of health research in policy-making: concepts, examples and methods of assessment

  2003cited by this paper
• Malaria control: constraints and opportunities

  2002cited by this paper
• Changing national malaria treatment protocols in Africa : What is the cost and who will pay ?

  2002cited by this paper
• Monitoring of drug-resistant malaria in Africa.

  2002cited by this paper
• Health policy-makers' perceptions of their use of evidence: a systematic review

  2002cited by this paper
• Social Research Methods: Qualitative and Quantitative Approaches

  2002cited by this paper
• Monitoring of drug-resistant malaria in Africa.

  2002cited by this paper
• Research that influences policy and practice – characteristics of operational research to improve malaria control in Mpumalanga Province, South Africa

  2002influential reference
• Increasing antimalarial drug resistance in Uganda and revision of the national drug policy

  2002influential reference
• Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development.

  2002cited by this paper
• Combination therapy for malaria: the way forward?

  2002cited by this paper
• Changing the first line drug for malaria treatment--cost-effectiveness analysis with highly uncertain inter-temporal trade-offs.

  2001cited by this paper
• Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience

  2001cited by this paper
• Global public goods and health: taking the agenda forward.

  2001cited by this paper
• Evidence based primary care? A multi-tier, multiple stakeholder perspective from Chile.

  2001cited by this paper
• Sentinel malaria surveillance--more than a research tool.

  2001cited by this paper
• Re.: Complex, and large, trials of pragmatic malaria interventions.

  2001cited by this paper
• Antimalarial drug combination policy: a caveat.

  2000cited by this paper
• Using evidence to change antimalarial drug policy in Kenya

  2000influential reference
• Coordinating health research to promote action: the Tanzanian experience

  2000cited by this paper
• Mothers, malaria and resistance.

  2000cited by this paper
• The costs, effects and cost-effectiveness of changing the first line drug for the treatment of malaria in Tanzania

  2000cited by this paper
• Patterns of care for childhood malaria in Zambia.

  2000cited by this paper
• Editorial: Mothers, malaria and resistance

  2000cited by this paper
• Informal economic activities of public health workers in Uganda: implications for quality and accessibility of care.

  1999cited by this paper
• Antimalarial drug policy: making systematic change.

  1999cited by this paper
• The evidence base on the cost-effectiveness of malaria control measures in Africa.

  1999cited by this paper
• Maternal responses to childhood fevers: a comparison of rural and urban residents in coastal Kenya

  1999cited by this paper
• A community perspective on the efficacy of malaria treatment options for children in Lundazi District, Zambia

  1999cited by this paper
• Cost-effectiveness of malaria control in sub-Saharan Africa.

  1999cited by this paper
• How do researchers influence decision-makers? Case studies of Mexican policies.

  1999cited by this paper
• Malaria-treatment policies: when and how should they be changed?

  1999cited by this paper
• Cost-effectiveness of malaria control in sub-Saharan Africa.

  1999cited by this paper
• Strategies to enhance the use of health systems research for health sector reform

  1999cited by this paper
• Making malaria-treatment policy in the face of drug resistance.

  1999influential reference
• Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub‐Saharan Africa

  1998cited by this paper
• A systematic approach to the development of a rational malaria treatment policy in Zambia

  1998cited by this paper
• Use of traditional and pharmaceutical medicines in Kenya: The case of Kisumu and Rachuonyo Districts in Luo Nyanza

  1998cited by this paper
• Economics and its contribution to the fight against malaria.

  1998cited by this paper
• South Africa's new national drug policy. Interview by Daphne Fresle.

  1997cited by this paper
• Household cost of seeking malaria care. A retrospective study of two districts in Ghana.

  1997cited by this paper
• Managing drug supply : the selection, procurement, distribution, and use of pharmaceuticals

  1997cited by this paper
• South Africa's New National Drug Policy

  1997cited by this paper
• The politics of health sector reform in developing countries: three cases of pharmaceutical policy.

  1995cited by this paper
• Health Policy -An introduction to process and power

  1995cited by this paper
• A decade of progress in malaria policy and program development in Malawi; 1984-1993

  1995cited by this paper
• Reforming the health sector in developing countries: the central role of policy analysis.

  1994cited by this paper
• The diagnosis and management of fever at household level in the Greater Accra Region, Ghana.

  1994cited by this paper
• Socioeconomic factors in malaria control.

  1994cited by this paper
• Community satisfaction with primary health care services: an evaluation undertaken in the Morogoro region of Tanzania.

  1994cited by this paper
• Socioeconomic factors in malaria control.

  1994cited by this paper
• Research Methods in Anthropology: Qualitative and Quantitative Approaches

  1988cited by this paper
• Improving health care policy research.

  1982cited by this paper
• Chloroquine-resistant Plasmodium falciparum malaria in Kenya.

  1979cited by this paper
• Combination therapy of malaria.

  1969cited by this paper
• ANTIMALARIAL DRUG COMBINATION THERAPY Report of a WHO Technical Consultation

  year unknowncited by this paper

• Genetic diversity, population structure, and drug resistance of Plasmodium falciparum in Kenya: a systematic review and meta-analysis

  2025cites this paper
• Evaluation of Segmentation, Rotation, and Geographic Delivery Approaches for Deployment of Multiple First-Line Treatment (MFT) to Respond to Antimalarial Drug Resistance in Africa: A Qualitative Study in Seven Sub-Sahara Countries

  2024cites this paper
• Therapeutic efficacy and safety of artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria treatment in Metehara, Central-east Ethiopia

  2024cites this paper
• A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria

  2023cites this paper
• Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion

  2023cites this paper
• The Impact of Discontinuity of the Country's Leadership in Each General Election on Country Progress and Development: A Multifaceted Analysis

  2022cites this paper
• Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study

  2022cites this paper
• National School Health Policy in Nigeria; Survey of teachers’ perception and implementation in public schools in Ebonyi State

  2022cites this paper
• In vitro antiplasmodial, molecular docking and pharmacokinetics studies of specialized metabolites from Tetrapleura tetraptera (Fabaceae)

  2022cites this paper
• Antimalarial, Antitrypanosomal, Antimicrobial Activities and Volatile Oil Profile of Xylopia aethiopica (Dunal) Rich (Annonaceae)

  2021cites this paper
• Country size bias in global health: cross-country comparison of malaria policy and foreign aid

  2021cites this paper
• Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations

  2021cites this paper
• Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol.

  2021cites this paper
• Further evidence needed to change policy for the safe and effective radical cure of vivax malaria: Insights from the 2019 annual APMEN Vivax Working Group meeting

  2021cites this paper
• A cross-country comparison of malaria policy as a premise for contextualized appropriation of foreign aid in global health

  2021cites this paper
• Market Formation in a Global Health Transition

  2021cites this paper
• To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?

  2021cites this paper
• Opening the policy blackbox: unravelling the process for changing national diagnostic and treatment guidelines for vivax malaria in seven countries

  2021cites this paper
• Adoption of evidence-based global policies at the national level: intermittent preventive treatment for malaria in pregnancy and first trimester treatment in Kenya, Malawi, Mali and The Gambia

  2020cites this paper
• Triple Artemisinin-Based Combination Therapies for Malaria - A New Paradigm?

  2020cites this paper
• The Economics of Vivax Malaria Treatment

  2018cites this paper
• POLICY ARENA OF HEALTH POLICY-MAKING PROCESS IN DEVELOPING COUNTRIES

  2018cites this paper
• [Impact on the transmission of malaria with different treatment schemes in the peruvian coast and amazon region within the framework of a policy on antimalarial medications, 1994-2017].

  2018cites this paper
• A New Village Movement towards Abatement of Malaria Epidemics in Sub -Saharan Africa: A Policy Design For Experimentation: Uganda

  2017cites this paper
• Supply chain management of anti-malarials in the district hospitals in Kumasi Metropolitan Area, Ashanti region of Ghana

  2017cites this paper
• Embedding researchers in health service organizations improves research translation and health service performance: the Australian Hunter New England Population Health example.

  2017cites this paper
• EFFECT OF POLICY CHANGE ON THE PRESCRIPTION PATTERN OF ANTIMALARIAL DRUGS OF DOCTORS IN BENIN CITY

  2017cites this paper
• Changing the policy for intermittent preventive treatment with sulfadoxine–pyrimethamine during pregnancy in Malawi

  2017cites this paper
• Health worker perspectives on the possible use of intramuscular artesunate for the treatment of severe malaria at lower-level health facilities in settings with poor access to referral facilities in Nigeria: a qualitative study

  2016cites this paper
• Accelerating Access to New Malaria Vector Control Tools: A National and Global Health Policy Analysis

  2016cites this paper
• Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia

  2016cites this paper
• Identifying barriers in the malaria control policymaking process in East Africa: insights from stakeholders and a structured literature review

  2015cites this paper
• Factors influencing the National School Health Policy implementation in Lao PDR: a multi-level case study.

  2015cites this paper
• National malaria vector control policy: an analysis of the decision to scale-up larviciding in Nigeria

  2015cites this paper
• The effect of intermittent preventive treatment on anti-malarial drug resistance spread in areas with population movement

  2014cites this paper
• Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya

  2014cites this paper
• The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of Tanzania

  2014cites this paper
• Changing the malaria treatment protocol policy in Timor-Leste: an examination of context, process, and actors’ involvement

  2013cites this paper
• Public health system readiness to treat malaria in Odisha State of India

  2013cites this paper
• Epidemiology of malaria in South Africa: from control to elimination.

  2013cites this paper
• The copyright of this thesis vests in the author. No quotation from it or information derived from it is to be published without full acknowledgement of the source

  2013cites this paper
• A Best Practices Model for Implementing Successful Electronic Disease Surveillance Systems: Insights from Peru and Around the Globe

  2013cites this paper
• Country planning for health interventions under development: lessons from the malaria vaccine decision-making framework and implications for other new interventions

  2012cites this paper
• Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework

  2012cites this paper
• Participatory healthcare-provider orientation to improve artemether-lumefantrine-based drug treatment of uncomplicated malaria: a cluster quasi-experimental study

  2012cites this paper
• Brokering the boundary between science and advocacy: the case of intermittent preventive treatment among infants

  2012cites this paper
• Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems.

  2012cites this paper
• The implementation of a new Malaria Treatment Protocol in Timor-Leste: challenges and constraints

  2012cites this paper
• Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making

  2011cites this paper
• Malaria Treatment Policy Change and Implementation: The Case of Uganda

  2011cites this paper
• Implications of the current tuberculosis treatment landscape for future regimen change.

  2011cites this paper
• Prescribing practices for malaria in a rural Ugandan hospital: evaluation of a new malaria treatment policy.

  2011cites this paper
• implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania

  2011cites this paper
• Quality assurance of malaria case management in an urban and in sub-rural health centres in Goma, Congo

  2011cites this paper
• IMPACT OF DELAYED INTRODUCTION OF SULPHADOXINE- PYRIMETHAMINE AND ARTEMETHER-LUMEFANTRINE ON MALARIA EPIDEMIOLOGY IN KWAZULU-NATAL, SOUTH AFRICA Submitted to: NELSON R. MANDELA SCHOOL OF MEDICINE UNIVERSITY OF KWAZULU-NATAL DURBAN SOUTH AFRICA For: Partial Fulfilment of the Requirement of Master of

  2010influential citation
• Challenges to implementation of artemisinin combination therapy policy in Uganda.

  2010cites this paper
• Policy brief on improving access to artemisinin-based combination therapies for malaria in Cameroon

  2010cites this paper
• Who Gets Prompt Access to Artemisinin-Based Combination Therapy? A Prospective Community-Based Study in Children from Rural Kilosa, Tanzania

  2010cites this paper
• The Union Tuberculosis regimen change in high-burden countries

  2010cites this paper
• Tuberculosis regimen change in high-burden countries.

  2010cites this paper
• Availability of Antimalarial Drugs and Evaluation of the Attitude and Practices for the Treatment of Uncomplicated Malaria in Bangui, Central African Republic

  2010cites this paper
• Ensuring that Developing Countries have Access to New Healthcare Products: The Role of Product Development Partnerships

  2010cites this paper
• Immediate Responses by Private and Public Hospitals to National Malaria Treatment Policy Change Pronouncements in Uganda

  2010cites this paper
• The impact of stakeholder collaboration on effectiveness of health program implementation in Ghana

  2010cites this paper
• Soft targets or partners in health? Retail pharmacies and their role in Tanzania's malaria control program.

  2010cites this paper
• Cultural interpretations of the efficacy and side effects of antimalarials in Tanzania

  2009cites this paper
• Intermittent preventive treatment for malaria and anaemia control in Tanzanian infants; the development and implementation of a public health strategy.

  2009cites this paper
• Malaria drug shortages in Kenya: a major failure to provide access to effective treatment.

  2009cites this paper
• Impact of delayed introduction of sulfadoxine–pyrimethamine and arthemeter–lumefantrine on malaria epidemiology in KwaZulu‐Natal, South Africa

  2009cites this paper
• A retrospective analysis of the change in anti-malarial treatment policy: Peru

  2009influential citation
• Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon

  2009cites this paper
• From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia

  2008cites this paper
• Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies

  2008cites this paper
• A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya

  2008cites this paper
• Poor knowledge on new malaria treatment guidelines among drug dispensers in private pharmacies in Tanzania: the need for involving the private sector in policy preparations and implementation.

  2008cites this paper
• Knowledge and practices of patent medicine vendors in the use of artemisinin based combination therapy in the treatment of malaria in an urban community in Lagos

  2008cites this paper
• Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study

  2007cites this paper
• In vivo anti-malarial activity of hydroalcoholic extracts from Asparagus africanus Lam. in mice infected with Plasmodium berghei

  2007cites this paper
• Fixed-dose chloroquine and sulfadoxine/pyrimethamine treatment of malaria : Outcome and pharmacokinetic aspects

  2007cites this paper
• Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis.

  2007cites this paper
• Home-based management of fever and malaria treatment practices in Uganda.

  2007cites this paper
• Antimicrobial and cytotoxic activity of Marrubium alysson and Retama raetam grown in Tunisia.

  2007cites this paper
• IMPACT OF DELAYED INTRODUCTIONOF SULPHADOXINE­ PYRIMETHAMINEAND ARTEMETHER-LUMEFANTRINEON MALARIA EPIDEMIOLOGYIN KWAZULU-NATAL, SOUTH AFRICA

  2007cites this paper
• Managing childhood malaria in rural Tanzania : Focusing on drug use and resistance

  2006influential citation
• Rol del estado en la investigación científica en salud y transparencia en la información

  2006cites this paper
• [Knowledge and practice among health workers from the Thiès region with regard to new malaria treatment policies].

  2006cites this paper
• From chloroquine to artemisinin-based combination therapy: the Sudanese experience

  2006cites this paper
• Prevention of malaria during pregnancy in West Africa: policy change and the power of subregional action

  2006cites this paper
• Epidemiología, diagnóstico y tratamiento de malaria en el hospital de Borbón, provincia de Esmeraldas, en el periodo 2001-2005

  2006cites this paper
• Ensuring Supplies of Appropriate Drugs and Vaccines

  2006cites this paper
• The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania

  2006influential citation
• Quality of treatment for febrile illness among children at outpatient facilities in sub-Saharan Africa

  2006cites this paper
• Connaissances et pratiques des agents de santé de la région de Thiès concernant la nouvelle thérapie des accès palustres

  2006cites this paper
• Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study

  2005cites this paper
• Adoption of the new antimalarial drug policy in Tanzania – a cross‐sectional study in the community

  2005influential citation
• Malaria Journal Why Don't Health Workers Prescribe Act? a Qualitative Study of Factors Affecting the Prescription of Artemether-lumefantrine

  year unknowncites this paper
• Covered in Scopus & Embase, Elsevier PREDICTORS OF ADHERENCE TO NATIONAL ANTI-MALARIAL TREATMENT GUIDELINES IN SOME NIGERIAN HOSPITALS

  year unknowncites this paper
• Infection and Drug Resistance Dovepress Acquired Resistance of Malarial Parasites against Artemisinin-based Drugs: Social and Economic Impacts

  year unknowncites this paper
• Prescribe Act? a Qualitative Study of Factors Affecting the Prescription of Artemether-lumefantrine Malaria Journal Why Don't Health Workers Prescribe Act? a Qualitative Study of Factors Affecting the Prescription of Artemether-lumefantrine

  year unknowncites this paper
• Risk Management and Healthcare Policy Dovepress Implementation of Artemether-lumefantrine Treatment Policy for Malaria at Health Facilities in Tanzania

  year unknowncites this paper